CLOV (Clover Health Investments, Corp.) Stock Financials & Earnings | Market Cap Arena

CLOVClover Health Investments, Corp.

Mkt Cap$1B

Healthcare·Medical - Healthcare Plans·🇺🇸 United States·NASDAQ

Revenue (TTM)$1.9B

Net Income (TTM)-$86M

EPS (TTM)-$0.17

Free Cash Flow (TTM)-$69M

Gross Margin18.5%

Op. Margin-4.4%

Net Margin-4.4%

FCF Margin-3.6%

P/S Ratio (TTM)0.5x

P/E Ratio (TTM)—

YoY Rev Growth+40.3%

Employees—

Earnings Reports

Revenue & Profitability

Quarter	Revenue	Gross Profit	Op. Income
Q1 23	$322M	$47M	-$80M
Q2 23	$320M	$76M	-$29M
Q3 23	$306M	$70M	-$34M
Q4 23	$510M	$62M	-$66M
Q1 24	$347M	$82M	-$23M
Q2 24	$356M	$108M	$7M
Q3 24	$331M	$81M	-$9M
Q4 24	$337M	$94M	-$21M
Q1 25	$462M	$109M	-$1M
Q2 25	$478M	$100M	-$11M
Q3 25	$497M	$73M	-$24M
Q4 25	$488M	$74M	-$49M

Valuation

Quarter	P/S	P/E
Q1 23	0.4x	—
Q2 23	0.4x	—
Q3 23	0.6x	—
Q4 23	0.7x	—
Q1 24	0.7x	—
Q2 24	0.7x	—
Q3 24	0.7x	—
Q4 24	0.8x	—
Q1 25	0.7x	—
Q2 25	0.7x	—
Q3 25	0.6x	—
Q4 25	0.5x	—

Operating Cash Flow

Quarter	Operating CF	Free CF
Q1 23	$79M	$79M
Q2 23	$53M	$53M
Q3 23	-$19M	-$19M
Q4 23	-$258M	-$258M
Q1 24	$26M	$25M
Q2 24	$45M	$44M
Q3 24	$50M	$50M
Q4 24	-$86M	-$86M
Q1 25	-$16M	-$16M
Q2 25	$5M	$5M
Q3 25	$12M	$11M
Q4 25	-$68M	-$69M

Capital Expenditures

CapEx

Quarter	CapEx
Q1 23	$251K
Q2 23	$354K
Q3 23	$243K
Q4 23	$264K
Q1 24	$445K
Q2 24	$397K
Q3 24	$399K
Q4 24	$315K
Q1 25	$185K
Q2 25	$569K
Q3 25	$692K
Q4 25	$597K

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q1 23	-63.2%	-58.2%
Q2 23	-62.2%	-63.2%
Q3 23	-64.3%	-63.5%
Q4 23	-43.2%	-42.7%
Q1 24	+7.7%	-8.0%
Q2 24	+11.3%	+0.0%
Q3 24	+8.2%	+0.0%
Q4 24	-34.0%	-37.8%
Q1 25	+33.3%	+25.4%
Q2 25	+34.1%	+39.9%
Q3 25	+50.1%	+53.3%
Q4 25	+44.7%	+49.8%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q1 23	$39M	12.0%
Q2 23	$36M	11.3%
Q3 23	$33M	10.8%
Q4 23	$33M	6.5%
Q1 24	$29M	8.3%
Q2 24	$28M	7.8%
Q3 24	$28M	8.5%
Q4 24	$30M	8.8%
Q1 25	$26M	5.7%
Q2 25	$26M	5.5%
Q3 25	$26M	5.3%
Q4 25	$25M	5.1%

OpEx Breakdown

Quarter	G&A
Q1 23	$127M
Q2 23	$104M
Q3 23	$102M
Q4 23	$110M
Q1 24	$104M
Q2 24	$100M
Q3 24	$90M
Q4 24	$115M
Q1 25	$110M
Q2 25	$110M
Q3 25	$97M

War Chest

Quarter	Cash	Short-term Investments	Total
Q1 23	$191M	$226M	$417M
Q2 23	$310M	$211M	$521M
Q3 23	$299M	$218M	$517M
Q4 23	$116M	$120M	$236M
Q1 24	$208M	$134M	$342M
Q2 24	$255M	$124M	$379M
Q3 24	$288M	$45M	$333M
Q4 24	$195M	$27M	$222M
Q1 25	$155M	$5M	$160M
Q2 25	$189M	$11M	$200M
Q3 25	$190M	$13M	$203M
Q4 25	$78M	$17M	$95M

Shares Outstanding

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change
Q1 23	479M	+0.2%
Q2 23	479M	+0.1%
Q3 23	481M	+0.3%
Q4 23	482M	+0.2%
Q1 24	567M	+17.8%
Q2 24	495M	-12.7%
Q3 24	490M	-1.0%
Q4 24	492M	+0.3%
Q1 25	497M	+1.1%
Q2 25	509M	+2.4%
Q3 25	513M	+0.8%
Q4 25	517M	+0.9%

Revenue Per Employee

Revenue / Employee

Year	Revenue/Employee	Employees
FY 18	—	—
FY 19	—	—
FY 20	$1M	458
FY 21	$2M	680
FY 22	$2M	656
FY 23	$2M	552
FY 24	$2M	570
FY 25	$3M	724

CLOV (Clover Health Investments, Corp.) Stock Financials & Earnings | Market Cap Arena